[go: up one dir, main page]

EP3283650A4 - METHOD AND SYSTEM FOR CHARACTERIZATION, DIAGNOSIS AND TREATMENT DERIVED FROM MICROBIOMA OF DISORDERS ASSOCIATED WITH FUNCTIONAL CHARACTERISTICS - Google Patents

METHOD AND SYSTEM FOR CHARACTERIZATION, DIAGNOSIS AND TREATMENT DERIVED FROM MICROBIOMA OF DISORDERS ASSOCIATED WITH FUNCTIONAL CHARACTERISTICS Download PDF

Info

Publication number
EP3283650A4
EP3283650A4 EP16780662.9A EP16780662A EP3283650A4 EP 3283650 A4 EP3283650 A4 EP 3283650A4 EP 16780662 A EP16780662 A EP 16780662A EP 3283650 A4 EP3283650 A4 EP 3283650A4
Authority
EP
European Patent Office
Prior art keywords
microbioma
characterization
diagnosis
disorders associated
functional characteristics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16780662.9A
Other languages
German (de)
French (fr)
Other versions
EP3283650A1 (en
Inventor
Zachary APTE
Daniel Almonacid
Jessica RICHMAN
Siavosh Rezvan BEHBAHANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macrogen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3283650A1 publication Critical patent/EP3283650A1/en
Publication of EP3283650A4 publication Critical patent/EP3283650A4/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Databases & Information Systems (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Artificial Intelligence (AREA)
  • Software Systems (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Primary Health Care (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP16780662.9A 2015-04-13 2016-04-13 METHOD AND SYSTEM FOR CHARACTERIZATION, DIAGNOSIS AND TREATMENT DERIVED FROM MICROBIOMA OF DISORDERS ASSOCIATED WITH FUNCTIONAL CHARACTERISTICS Pending EP3283650A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562146818P 2015-04-13 2015-04-13
US201562147096P 2015-04-14 2015-04-14
US201562147334P 2015-04-14 2015-04-14
PCT/US2016/027349 WO2016168344A1 (en) 2015-04-13 2016-04-13 Method and system for microbiome-derived characterization, diaganostics and therapeutics for conditions associated with functional features

Publications (2)

Publication Number Publication Date
EP3283650A1 EP3283650A1 (en) 2018-02-21
EP3283650A4 true EP3283650A4 (en) 2019-04-10

Family

ID=57126060

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16780662.9A Pending EP3283650A4 (en) 2015-04-13 2016-04-13 METHOD AND SYSTEM FOR CHARACTERIZATION, DIAGNOSIS AND TREATMENT DERIVED FROM MICROBIOMA OF DISORDERS ASSOCIATED WITH FUNCTIONAL CHARACTERISTICS

Country Status (4)

Country Link
EP (1) EP3283650A4 (en)
CN (1) CN107849616B (en)
AU (2) AU2016250096A1 (en)
WO (1) WO2016168344A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018094376A1 (en) * 2016-11-21 2018-05-24 uBiome, Inc. Method and system for characterizing a headache-related condition
WO2018112437A1 (en) * 2016-12-15 2018-06-21 uBiome, Inc. Method and system for characterizing allergy-related conditions associated with microorganisms
WO2018112419A1 (en) * 2016-12-15 2018-06-21 uBiome, Inc. Method and system for characterizing diet-related conditions
WO2018112459A1 (en) * 2016-12-16 2018-06-21 uBiome, Inc. Method and system for characterizing microorganism-related conditions
EP3803901A1 (en) * 2018-06-07 2021-04-14 4D Pharma Plc Method for stratifying ibs patients
JP2022527802A (en) * 2019-03-29 2022-06-06 プソマーゲン， インコーポレイテッド By-products of the microbial flora and their use
CN115691813A (en) * 2022-12-30 2023-02-03 神州医疗科技股份有限公司 Genetic gastric cancer assessment method and system based on genomics and microbiomics

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
US20140315929A1 (en) * 2011-04-28 2014-10-23 Sloan-Kettering Institute For Cancer Research Hsp90 combination therapy
WO2015013214A2 (en) * 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
AU2006311583A1 (en) * 2005-11-09 2007-05-18 Primeradx, Inc. Multiplexed quantitative detection of pathogens
WO2012050513A1 (en) * 2010-10-11 2012-04-19 Baeckhed Fredrik Method for identifying a risk of cardiovascular disease by analysing oral microbiota
US20140341853A1 (en) * 2013-05-14 2014-11-20 Vanna Hovanky Bacteria-Mediated Therapy for Cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140315929A1 (en) * 2011-04-28 2014-10-23 Sloan-Kettering Institute For Cancer Research Hsp90 combination therapy
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
WO2015013214A2 (en) * 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KANEHISA M ET AL: "The KEGG resource for deciphering the genome", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, vol. 32, 1 January 2004 (2004-01-01), pages D277 - D280, XP002992338, ISSN: 0305-1048, DOI: 10.1093/NAR/GKH063 *
See also references of WO2016168344A1 *

Also Published As

Publication number Publication date
CN107849616A (en) 2018-03-27
WO2016168344A1 (en) 2016-10-20
EP3283650A1 (en) 2018-02-21
AU2022203347A1 (en) 2022-06-09
AU2016250096A1 (en) 2017-11-09
WO2016168344A8 (en) 2018-07-26
AU2016250096A8 (en) 2018-12-06
CN107849616B (en) 2022-03-29

Similar Documents

Publication Publication Date Title
EP3283650A4 (en) METHOD AND SYSTEM FOR CHARACTERIZATION, DIAGNOSIS AND TREATMENT DERIVED FROM MICROBIOMA OF DISORDERS ASSOCIATED WITH FUNCTIONAL CHARACTERISTICS
EP3347367A4 (en) METHOD AND SYSTEM FOR DIAGNOSIS AND THERAPY DERIVED FROM MICROBIOMA FOR BACTERIAL VAGINOSIS
EP4049580C0 (en) METHODS AND SYSTEM FOR MONITORING AMETROPIA TREATMENT
EP3913857A4 (en) INTENT TREATMENT METHOD, APPARATUS AND SYSTEM
EP3346910A4 (en) METHOD AND SYSTEM FOR DIAGNOSES DERIVED FROM MICROBIOMA AND THERAPEUTIC AGENTS AGAINST ECZEMA
EP3389725A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
EP3370617A4 (en) NON-INVASIVE SYSTEM FOR IMAGING AND TREATING CARDIAC ARRHYTHMIAS
EP3383470A4 (en) FLOW PATH DETECTION FOR FLOW TREATMENT APPARATUS
EP3307754A4 (en) COMPOSITIONS OF NICOTINAMIDE RIBOSIDE AND PTEROSTILBENE AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
MX388142B (en) HUMANIZED TAU ANTIBODIES IN ALZHEIMER'S DISEASE.
EP3333661A4 (en) ANOMALY PREDICTOR DIAGNOSIS SYSTEM AND ANOMALY PREDICTOR DIAGNOSIS METHOD
EP2773779A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF NEUROLOGICAL CONDITIONS
EP3283648A4 (en) METHOD AND SYSTEM FOR DIAGNOSING DERIVATIVES OF MICROBIOMA AND TREATING THERAPEUTIC PROBLEMS FOR NEUROLOGICAL HEALTH PROBLEMS
EP3488413A4 (en) SYSTEM AND METHOD FOR ESTIMATING SYNTHETIC QUANTITATIVE HEALTH VALUES FROM MEDICAL IMAGES
EP3347084A4 (en) AORTIC CANNULA FOR EX VIVO ORGAN TREATMENT SYSTEM
EP3368754A4 (en) METHOD AND SYSTEM FOR DIAGNOSING A SYSTEM AFTER PROCESSING
EP3376939A4 (en) AUTOMATIC PROCEDURE FOR THE OBJECTIVE QUANTIFICATION OF RETAIL PROPERTIES BY RETIREMENT REGION AND DIAGNOSIS OF RETAIL SKIN PATHOLOGY
EP3386520A4 (en) METHODS OF TREATING EYE DISEASE OR DISORDER
EP3522900A4 (en) COMPOUNDS AND METHODS FOR DIAGNOSING AND TREATING VIRAL INFECTIONS
EP3395227A4 (en) ENDOSCOPE SYSTEM AND METHOD OF OPERATING ENDOSCOPE SYSTEM
EP3283085A4 (en) METHOD AND SYSTEM FOR MICROBIOMA DERIVATIVES AND DIAGNOSES FOR AFFECTIONS ASSOCIATED WITH MICROBIOMA TAXONOMIC ELEMENTS
EP2723866A4 (en) METHODS OF PROGNOSIS AND / OR DIAGNOSIS OF NEURODEGENERATIVE DISEASE, METHODS OF IDENTIFYING CANDIDATE COMPOUNDS AND COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASE
MA42616A (en) FIXED DOSE COMBINATIONS AND FORMULATIONS INCLUDING ETC1002 AND EZETIMIBE, AND METHODS FOR TREATING OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE
MA55917A (en) METHOD FOR CRYSTALLIZING ARIPIPRAZOLE DERIVATIVES INTO EXTENDED-RELEASE FORMULATIONS FOR THE TREATMENT OF SCHIZOPHRENIA
EP3402477A4 (en) METHODS FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH SUPPRESSIVE CELLS DERIVED FROM MYELOID CELLS

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171020

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/569 20060101ALI20181025BHEP

Ipc: G16H 50/20 20180101ALI20181025BHEP

Ipc: G06F 19/18 20110101AFI20181025BHEP

Ipc: C12Q 1/68 20180101ALI20181025BHEP

Ipc: G01N 33/48 20060101ALI20181025BHEP

Ipc: G06F 19/24 20110101ALI20181025BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20190314

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20180101AFI20190311BHEP

Ipc: G16H 50/20 20180101ALI20190311BHEP

Ipc: G01N 33/569 20060101ALI20190311BHEP

Ipc: G01N 33/48 20060101ALI20190311BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20191015

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

D18D Application deemed to be withdrawn (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231129

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: MACROGEN INC.